Amgen Technology Private Limited

Amgen Technology Private Limited - research & development in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U62099MH2007FTC168485 Incorporated 08 March 2007 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company research and development
Revenue · FY 2025
₹166.38 Cr
▲ 601% YoY
Net profit · FY 2025
₹12.46 Cr
Net margin 7.5%
EBITDA · FY 2025
₹29.68 Cr
EBITDA margin 17.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
19 yrs
Est. 2007
Employees · EPFO
3,234
Provident fund records
Directors on board
5
As per MCA filings

About Amgen Technology Private Limited

Data last updated:

Amgen Technology Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Amgen Worldwide Holdings B V. It operates in the research and development sector. It was incorporated on 08 March 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U62099MH2007FTC168485. Its GSTIN is 27AAGCA2156C1Z3 (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Naveen Gullapalli (Whole-Time Director) and Mihir Kumar Ojha (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Park, Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹166.38 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹12.46 Cr (net margin 7.5%) and EBITDA of ₹29.68 Cr (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 42% over five years.

The company has about 3,234 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Amgen. The company has 1 deal on record (1 secondary share transfer); the latest was in November 2008. Its 5 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 3 smaller; the largest is Laxai Life Sciences Private Limited with revenue of ₹178 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amgen.com.

Company details

CIN U62099MH2007FTC168485
Registration Number 168485
Incorporation Date 08 March 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Amgen Worldwide Holdings B V
Compliance Status Active Compliant

CIN history

Amgen Technology has one previous CIN (Corporate Identification Number): U24110MH2007FTC168485. The current CIN is U62099MH2007FTC168485, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U62099MH2007FTC168485Current
U24110MH2007FTC168485Previous

Contact details

Amgen Technology Private Limited's registered office is in Mumbai, Maharashtra. Its website is amgen.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    10th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon (E) Nesco I., T. Park, Mumbai, Maharashtra, India – 400063
  • Industry
    Research & Development, Research & Development

To see the full contact details of Amgen Technology Private Limited, buy the company report.

Comprehensive company report
Amgen Technology Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Amgen Technology operates one associated brand: Amgen. Each brand links to its own profile.

BrandDescriptionWebsite
Developer of pharmaceutical products for treating multiple diseasesamgen.com

Business activity

The main business activity of Amgen Technology is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Amgen Technology Private Limited, buy the company report.

Financials of Amgen Technology Private Limited

FY 2024 filings available

Amgen Technology Private Limited reported revenue of ₹166.38 Cr (up 601% YoY) for FY 2025.

Revenue · FY 2025
₹166.38 Cr ▲ 601%
Net profit · FY 2025
₹12.46 Cr margin 7.5%
EBITDA · FY 2025
₹29.68 Cr margin 17.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 601%
3 years · compounded
▲ 79%
5 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▲ 450%
3 years · compounded
▲ 74%
5 years · compounded
▲ 41%

Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 601% growth in the latest year. EBITDA rose 450% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹29.68 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.46 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin17.8%
Net Profit Margin7.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Amgen Technology Private Limited, buy the company report.

Board of directors of Amgen Technology Private Limited

Amgen Technology has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mansi Jayantilal MalkanDirector15 Sep 20179 Years 2 MonthsCurrent
David Ewan FoulstoneDirector20 Mar 20242 Years 7 MonthsCurrent
Ng Lian Eric TeckDirector31 Aug 20179 Years 2 MonthsCurrent
Naveen GullapalliWhole-Time Director23 Apr 20251 Years 6 MonthsCurrent
Mihir Kumar OjhaWhole-Time Director09 May 20251 Years 6 MonthsCurrent

Peer comparison

Amgen Technology Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Laxai Life Sciences Private Limited₹178 Cr (FY 2024)37.0%Hyderabad, Telangana, India
Aurigene Oncology Limited₹171.93 Cr (FY 2025)-57.0%Bangalore, Karnataka, India
Amgen Technology Private Limitedthis company₹166.38 Cr (FY 2025)₹12.46 Cr7.5%601.0%3,234Mumbai, Maharashtra, India
Jamp India Pharmaceuticals Private Limited₹155.09 Cr (FY 2025)19.0%Ahmedabad, Gujarat, India
Raptim Research Private Limited₹146.15 Cr (FY 2025)-4.0%Navi Mumbai, Maharashtra, India
Synzeal Research Private Limited₹144.48 Cr (FY 2025)19.0%Bavla, Gujarat, India

To see the full peer comparison of Amgen Technology Private Limited, buy the company report.

Auditor

Amgen Technology Private Limited is audited by S R B C & CO LLP for the financial year 2022.

Auditor firmFinancial yearFirm registration number
S R B C & CO LLPFY 2022324982E

Shareholding

The shareholding of Amgen Technology Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Amgen Technology Private Limited, buy the company report.

Deals & funding

Amgen Technology Private Limited has 1 deal on record (1 secondary share transfer); the latest was in November 2008.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Nov 2008Secondary share transferUndisclosedBuyer: Amgen Worldwide Holdings B V
Seller: Amgen International Inc

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Amgen Technology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Amgen Technology Private Limited has a workforce of 3,234 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
3,234
Active EPFO establishments
1
Employee growth
342.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-273,234
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Amgen Technology Private Limited, buy the company report.

GST

Amgen Technology has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCA2156C1Z3MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Amgen Technology Private Limited, buy the company report.

Recent activity

Amgen Technology Private Limited has 17 board changes on record since 2008: 5 appointments and 12 cessations. The latest: Mihir Kumar Ojha was appointed as Whole-Time Director on 09 May 2025.

Appointed
Mihir Kumar Ojha was appointed as Whole-Time Director.
Appointed
Naveen Gullapalli was appointed as Whole-Time Director.
AGM
Amgen Technology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
David Ewan Foulstone ceased to be Additional Director.
Filing
Amgen Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
David Ewan Foulstone was appointed as Director.
Ceased
Shalabh Sachdeva ceased to be Additional Director.
Ceased
Vinod Mattoo ceased to be Additional Director.
Ceased
Sonika Shah ceased to be Director.
Ceased
Sagar Prabhakar Patil ceased to be Director.
Ceased
Mansi Jayantilal Malkan ceased to be Additional Director.
Ceased
Ng Lian Eric Teck ceased to be Additional Director.

8 earlier events are in the company report.

Frequently asked questions

Amgen Technology is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in the research and development industry. It was incorporated on 08 March 2007 (19+ years old) and is registered under CIN U62099MH2007FTC168485.

Amgen Technology has 5 current directors:

The latest financial statements of Amgen Technology on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Amgen Technology is 27AAGCA2156C1Z3, registered in Maharashtra.

The CIN (Corporate Identification Number) of Amgen Technology is U62099MH2007FTC168485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Amgen Technology was incorporated on 08 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.

Amgen Technology has 1 deal on record (1 secondary share transfer); the latest was in November 2008.

The peers of Amgen Technology by revenue are Laxai Life Sciences Private Limited, Aurigene Oncology Limited, Jamp India Pharmaceuticals Private Limited, Raptim Research Private Limited, Synzeal Research Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

Mihir Kumar Ojha was appointed as Whole-Time Director on 09 May 2025. Naveen Gullapalli was appointed as Whole-Time Director on 23 Apr 2025. David Ewan Foulstone ceased to be Additional Director on 25 Sep 2024. Amgen Technology has 17 board changes on record in total.

Amgen Technology can be reached through the website amgen.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Amgen Technology is at 10th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon E Nesco I., T. Park, Mumbai, Maharashtra, India – 400063.